Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Systematic approaches to central nervous system myelin.
Abnormalities of Motor Imagery and Relationship With Depressive Symptoms in Mildly Disabling Relapsing-Remitting Multiple Sclerosis.
BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety.
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF JC virus testing.
Influence of cigarette smoking on white matter in patients with clinically isolated syndrome as detected by diffusion tensor imaging.
The unidimensional self-efficacy scale for MS (USE-MS): developing a patient based and patient reported outcome.
Celiac disease and multiple sclerosis in the northwest of Iran.
Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis.
Effects of natalizumab treatment on the CSF proteome of multiple sclerosis patients.
Improving Hand Functional Use in Subjects with Multiple Sclerosis Using a Musical Keyboard: A Randomized Controlled Trial.
Platelets Contribute to the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Multiple sclerosis and progressive resistance training: a systematic review.
Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment.
Treatment of walking impairment in multiple sclerosis with dalfampridine.
Long-term follow-up of vanishing tumors in the brain: How should a lesion mimicking primary CNS lymphoma be managed?
Unprovoked seizures in multiple sclerosis and systemic lupus erythematosus: A population-based case-control study.
Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial.
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
Food and Drug Administration briefing document for ofatumumab
Animal Models in Neurology: Drawbacks and Opportunities.
Evidence-based guideline: Assessment and management of psychiatric disorders in individuals with MS: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Receptos begins enrollment of Phase 3 trial of RPC1063 in relapsing multiple sclerosis
Dispositional optimism is unidimensional or bidimensional? The Portuguese revised Life Orientation Test.

Pages